The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?

Hejna, M

The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology May 2002 - 653-68 p. digital

Publication Type: Journal Article; Review

0923-7534

10.1093/annonc/mdf142 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Female
Humans
Male
Neoplasms--diagnosis
Octreotide--adverse effects
Peptides, Cyclic--adverse effects
Randomized Controlled Trials as Topic
Sensitivity and Specificity
Somatostatin--adverse effects
Survival Analysis
Treatment Outcome